Macrophage inflammatory protein-1 alpha is produced by human multiple myeloma (MM) cells and its expression correlates with bone lesions in patients with MM

Br J Haematol. 2003 Jan;120(1):53-5. doi: 10.1046/j.1365-2141.2003.04040.x.

Abstract

Macrophage inflammatory protein-1 alpha (MIP-1alpha) is a chemokine primarily associated with bone absorption. We examined whether MIP-1alpha was produced by purified fresh tumour cells isolated from bone marrow samples from 31 multiple myeloma (MM) patients. High levels of MIP-1alpha were found in supernatants of myeloma cell cultures. Immunohistochemical staining showed MIP-1alpha in the cytoplasm of myeloma cells. MIP-1alpha mRNA expression was detected in 18 of 31 patients. Bone lesions were seen in 16 of the 18 MIP-1alpha-positive patients but only in six of the 13 MIP-1alpha-negative patients (P = 0.0097,chi2-test). The data indicate that MIP-1alpha is produced by myeloma cells and possibly plays a role in the pathogenesis of bone lesions in MM patients.

MeSH terms

  • Aged
  • Biomarkers / analysis
  • Bone Diseases / metabolism*
  • Bone Marrow Cells / chemistry*
  • Chemokine CCL3
  • Chemokine CCL4
  • Chi-Square Distribution
  • Cytoplasm / chemistry
  • Female
  • Humans
  • Immunohistochemistry
  • Macrophage Inflammatory Proteins / analysis*
  • Macrophage Inflammatory Proteins / genetics
  • Male
  • Middle Aged
  • Multiple Myeloma / metabolism*
  • RNA, Messenger / analysis
  • Reverse Transcriptase Polymerase Chain Reaction
  • Tumor Cells, Cultured

Substances

  • Biomarkers
  • Chemokine CCL3
  • Chemokine CCL4
  • Macrophage Inflammatory Proteins
  • RNA, Messenger